MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-12-2026
Baxter International Total Liabilities 2011-2026 | BAX
Annual Total Liabilities Baxter International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 B | 18.8 B | 19.8 B | 22.4 B | 24.4 B | 11.3 B | 10.3 B | 7.82 B | 8 B | 7.27 B | 12.1 B | 17.8 B | 17.4 B | 13.4 B | 12.2 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 24.4 B | 7.27 B | 14.5 B |
Quarterly Total Liabilities Baxter International
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.9 B | 13.8 B | 14.2 B | 18.7 B | 18.6 B | 19.6 B | 22.5 B | 22.3 B | 22.4 B | 22.4 B | 22.4 B | - | 23.6 B | 24.4 B | 11 B | 11.1 B | 11 B | 11.3 B | 11.3 B | 11.3 B | 11.3 B | 10.3 B | 10.3 B | 10.3 B | 10.3 B | 7.85 B | 7.85 B | 7.82 B | 7.82 B | 8 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 24.4 B | 7.82 B | 14.4 B |
Total Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
17.9 K | - | - | $ 810 M |  USA |
 |
Luminex Corporation
LMNX
|
308 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
1.53 M | - | -9.52 % | $ 20.6 M | USA |
 |
Alcon
ALC
|
9.52 B | $ 76.58 | 1.05 % | $ 40.4 B |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
11.1 M | $ 11.19 | 1.85 % | $ 27.1 M | USA |
 |
The Cooper Companies
COO
|
4.16 B | $ 64.76 | 0.52 % | $ 12.9 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
93.4 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
1.34 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
85.8 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.94 B | - | -0.05 % | $ 10.3 B | USA |
 |
iRhythm Technologies
IRTC
|
867 M | $ 125.16 | 2.3 % | $ 4.01 B | USA |
 |
Repro Med Systems
KRMD
|
11.2 M | $ 3.94 | -0.51 % | $ 182 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
2.38 B | - | -0.02 % | $ 16.3 B | USA |
 |
Milestone Scientific
MLSS
|
4.99 M | $ 0.31 | -2.41 % | $ 25.4 M | USA |
 |
Haemonetics Corporation
HAE
|
680 M | $ 59.95 | -0.05 % | $ 3.02 B | USA |
 |
electroCore
ECOR
|
20.4 M | $ 6.1 | -1.21 % | $ 51.7 K | USA |
 |
ICU Medical
ICUI
|
315 M | $ 121.97 | -2.29 % | $ 3.01 B | USA |
 |
Microbot Medical
MBOT
|
3.99 M | $ 2.21 | 0.45 % | $ 101 M |  Israel |
 |
Envista Holdings Corporation
NVST
|
2.62 B | $ 27.04 | 0.93 % | $ 4.54 B | USA |
 |
Isoray
ISR
|
59.9 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
2.52 B | $ 482.7 | 0.1 % | $ 172 B | USA |
 |
Glaukos Corporation
GKOS
|
479 M | $ 123.75 | 1.72 % | $ 5.99 B | USA |
 |
STERIS plc
STE
|
3.53 B | $ 221.43 | -0.17 % | $ 21.8 B | USA |
 |
Masimo Corporation
MASI
|
1.57 B | $ 178.55 | -0.04 % | $ 9.52 B | USA |
 |
InfuSystem Holdings
INFU
|
51.4 M | $ 10.83 | 4.94 % | $ 224 M | USA |
 |
Teleflex Incorporated
TFX
|
3.82 B | $ 137.51 | 0.7 % | $ 6.14 B | USA |
 |
Merit Medical Systems
MMSI
|
1.1 B | $ 68.43 | -0.22 % | $ 4.05 B | USA |
 |
Utah Medical Products
UTMD
|
3.27 M | $ 68.25 | 1.61 % | $ 221 M | USA |
 |
Pulse Biosciences
PLSE
|
13.9 M | $ 23.51 | 2.11 % | $ 1.58 B | USA |
 |
West Pharmaceutical Services
WST
|
1.09 B | $ 308.57 | 0.88 % | $ 22.3 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
4.09 B | $ 11.98 | 0.67 % | $ 2.39 B | USA |
 |
Retractable Technologies
RVP
|
68.3 M | $ 0.65 | 1.41 % | $ 19.5 M | USA |
 |
Pro-Dex
PDEX
|
24.6 M | $ 52.07 | -0.06 % | $ 171 M | USA |
 |
LeMaitre Vascular
LMAT
|
222 M | $ 114.44 | 0.87 % | $ 2.59 B | USA |
 |
Predictive Oncology
POAI
|
5.17 M | - | - | $ 31.1 M | USA |
 |
STAAR Surgical Company
STAA
|
107 M | $ 26.27 | 2.34 % | $ 1.3 B | USA |
 |
BioLife Solutions
BLFS
|
50.6 M | $ 21.82 | 2.06 % | $ 1.01 B | USA |
 |
Stereotaxis
STXS
|
33.5 M | $ 1.92 | -0.78 % | $ 175 M | USA |
 |
ResMed
RMD
|
1.74 B | $ 221.41 | 0.77 % | $ 32.3 B | USA |
 |
AtriCure
ATRC
|
162 M | $ 28.94 | -1.16 % | $ 1.38 B | USA |
 |
Harvard Bioscience
HBIO
|
66.3 M | $ 6.88 | 0.29 % | $ 305 M | USA |
 |
NeuroMetrix
NURO
|
1.01 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
97.2 M | $ 11.26 | 1.4 % | $ 460 M | USA |
 |
Becton, Dickinson and Company
BDX
|
30.7 B | $ 153.02 | 0.59 % | $ 44 B | USA |
 |
Nephros
NEPH
|
3.5 M | $ 2.89 | 0.7 % | $ 30 M | USA |
 |
OraSure Technologies
OSUR
|
62.3 M | $ 3.01 | 0.33 % | $ 221 M | USA |
 |
Repligen Corporation
RGEN
|
866 M | $ 118.66 | 0.9 % | $ 6.61 M | USA |